|
Table 3: Cutoff points, sensibility, specificity, OR and 95%CI in complicated acute appendicitis. |
||||||
|
Study |
Cutoff value |
Sens (%) |
Spec (%) |
OR [95%CI] |
p |
Population |
|
Leukocytes |
||||||
|
HPC |
10,195 |
77.60 |
46.6 |
2.63 [1.5-4.6] |
0.001 |
C |
|
Al-Gaithy, (2012)21 |
11,100 |
76.62 |
72.41 |
NR |
< 0.001 |
A |
|
McGowan et al. (2013)22 |
11,000 |
81.20 |
36.70 |
2.61 [1.7-4.01] |
NR |
A |
|
Shimizu et al. (2016)23 |
11,500 |
NR |
NR |
NR |
< 0.001 |
A |
|
Beecher et al. (2016)24 |
12,250 |
70.03 |
68.13 |
NR |
NR |
A |
|
Aydin et al. (2016)25 |
13,800 |
53.30 |
67.00 |
3.10 [1.71-5.62] |
< 0.001 |
A |
|
Jung et al. (2016)26 |
10,600 |
71.20 |
68.20 |
5.29 [2.27-12.37] |
< 0.001 |
A |
|
Shin et al. (2018)27 |
10,750 |
81.80 |
75.00 |
4.39 [1.36-14.18] |
< 0.001 |
A |
|
Celik et al. (2019)28 |
14,870 |
86.10 |
41.60 |
NR |
0.001 |
C |
|
Prasetya et al. (2019)29 |
13,630 |
66.10 |
62.50 |
3.25 [1.53-6.90] |
0.008 |
C |
|
Vargas-Rodríguez et al. (2022)30 |
11,000 |
78.22 |
22.46 |
1.04 [0.56-1.93] |
NR |
A |
|
Patmano et al. (2022)31 |
13,610 |
70.10 |
53.70 |
1.21 [1.08-1.36] |
< 0.001 |
A |
|
Mekrugsakit & Tullavardhana, (2023)32 |
15,150 |
62.00 |
50.00 |
NR |
NR |
A |
|
Neutrophils |
||||||
|
HPC |
7,050 |
80.50 |
46.60 |
3.59 [2.02-6.39] |
< 0.001 |
C |
|
Al-Gaithy, (2012)21 |
7,540 |
81.82 |
65.52 |
NR |
< 0.001 |
A |
|
McGowan et al. (2013)22 |
7,000 |
88.30 |
29.60 |
1.98 [1.28-3.06] |
NR |
A |
|
Beecher et al. (2016)24 |
9,350 |
76.19 |
60.00 |
NR |
NR |
A |
|
Jung et al. (2016)26 |
8,100 |
71.20 |
65.90 |
4.77 [2.06-11.07] |
< 0.001 |
A |
|
Celik et al. (2019)28 |
76.00* |
97.20 |
32.20 |
NR |
< 0.001 |
C |
|
Prasetya et al. (2019)29 |
80.05* |
74.50 |
66.70 |
5.85 [2.62-13.05] |
< 0.0001 |
C |
|
Vargas-Rodríguez et al. (2022)30 |
85.00* |
54.46 |
65.94 |
2.17 [1.28-3.66] |
NR |
A |
|
Mekrugsakit & Tullavardhana, (2023)32 |
80.00* |
64.00 |
52.00 |
NR |
NR |
A |
|
Eosinophils |
||||||
|
HPC |
55.00 |
67.80 |
53.40 |
2.41 [1.40-4.16] |
0.001 |
C |
|
NLR |
||||||
|
HPC |
3.18 |
88.80 |
37.00 |
6.64 [2.44-8.83] |
< 0.001 |
C |
|
Ishizuka et al. (2012)33 |
8.00 |
73.00 |
39.00 |
3.02 [1.54-5.94] |
0.001 |
C+A |
|
Kahramanca et al. (2014)34 |
5.74 |
70.80 |
48.50 |
NR |
< 0.001 |
A |
|
Kelly et al. (2015)35 |
7.53 |
80.00 |
55.00 |
NR |
< 0.001 |
C |
|
Shimizu et al. (2016)23 |
5.00 |
NR |
NR |
NR |
< 0.001 |
A |
|
Yardımci et al. (2016)36 |
7.95 |
78.00 |
67.00 |
3.04 [2.46-5.22] |
0.001 |
C+A |
|
Beecher et al. (2016)24 |
5.47 |
78.43 |
70.33 |
NR |
NR |
A |
|
Aydin et al. (2016)25 |
4.87 |
70.70 |
56.30 |
3.03 [1.66-5.49] |
< 0.001 |
A |
|
Sevinc et al. (2016)37 |
4.80 |
78.40 |
41.70 |
2.60 [NR] |
NR |
C+A |
|
Jung et al. (2016)26 |
5.60 |
78.00 |
65.90 |
6.84 [2.85-16.43] |
< 0.001 |
A |
|
Khan et al. (2018)38 |
6.36 |
84.00 |
48.00 |
NR |
< 0.001 |
C+A |
|
Shin et al. (2018)27 |
6.90 |
61.80 |
75.00 |
5.65 [0.57-55.97] |
0.139 |
A |
|
Celik et al. (2019)28 |
2.87 |
61.10 |
73.20 |
NR |
< 0.001 |
C |
|
Prasetya et al. (2019)29 |
6.59 |
84.60 |
56.60 |
7.15 [2.28-22.40] |
< 0.001 |
C |
|
Hajibandeh et al. (2020)39‡ |
8.80 |
76.90 |
100.00 |
43.33 [3.90-481.82] |
< 0.001 |
C+A |
|
Begic-Kapetanovic et al. (2021)40 |
5.61 |
79.00 |
81.0 |
NR |
< 0.001 |
C |
|
Cruz-Vallejo et al. (2021)41 |
10.40 |
77.78 |
67.14 |
2.53 [1.27-5.05] |
< 0.001 |
C |
|
Rajalingam et al. (2022)42 |
6.96 |
26.50 |
91.60 |
3.95 [2.63-5.99] |
< 0.001 |
A |
|
Ayeni et al. (2022)43 |
8.86 |
70.30 |
70.00 |
NR |
< 0.001 |
C |
|
Prasetya et al. (2019)29 |
5.50 |
61.39 |
43.48 |
1.22 [0.82-1.52] |
NR |
A |
|
Patmano et al. (2022)31 |
6.69 |
77.00 |
76.30 |
NR |
< 0.001 |
A |
|
Mekrugsakit & Tullavardhana, (2023)32 |
7.40 |
62.00 |
58.00 |
NR |
NR |
A |
|
Ortiz-Ley et al. (2023)9 |
7.40 |
NR |
NR |
2.20 [0.63-7.66] |
0.20 |
C§ |
|
12.43 |
NR |
NR |
1.82 [0.76-4.37] |
0.17 |
C¶ |
|
|
16.80 |
NR |
NR |
2.26 [0.72-7.09] |
0.15 |
C|| |
|
|
Moreno-Alfonso et al. (2023)19 |
7.77 |
72.00 |
76.00 |
8.20 [4.00-16.40] |
NR |
C |
|
PLR |
||||||
|
HPC |
187.40 |
57.10 |
60.30 |
2.01 [1.17-3.47] |
0.011 |
C |
|
Shin et al. (2018)27 |
180.10 |
51.50 |
75.00 |
1.30 [0.29-5.79] |
0.727 |
A |
|
Celik et al. (2019)28 |
284.00 |
42.00 |
86.00 |
NR |
0.004 |
C |
|
Cruz-Vallejo et al. (2021)41 |
284.00 |
77.78 |
63.57 |
2.11 [1.09-4.08] |
< 0.001 |
C |
|
Rajalingam et al. (2022)42 |
180.50 |
22.40 |
89.00 |
2.35 [1.59-3.47] |
< 0.001 |
A |
|
Ayeni et al. (2022)43 |
193.67 |
64.00 |
61.00 |
NR |
< 0.001 |
C |
|
Mekrugsakit & Tullavardhana, (2023)32 |
144.40 |
55.00 |
44.00 |
NR |
NR |
A |
|
Ortiz-Ley et al. (2023)9 |
405.70 |
NR |
NR |
10.00 [1.10-90.59] |
0.049 |
C§ |
|
687.80 |
NR |
NR |
4.75 [0.53-42.54] |
0.270 |
C¶ |
|
|
504.70 |
NR |
NR |
2.78 [0.46-16.49] |
0.460 |
C|| |
|
|
Yesilalioglu et al. (2023)44 |
133.73 |
60.00 |
58.40 |
NR |
0.032 |
A |
|
Moreno-Alfonso et al. (2023)19 |
213.32 |
60.00 |
85.00 |
8.52 [3.90-18.30] |
NR |
C |
|
A = adults. C = children. CI = confidence interval. HPC = Hospital Pediátrico Coyoacán. NLR = neutrophil/lymphocyte ratio. NR = not reported. OR = odds ratio. PLR = platelet/lymphocyte ratio. Sens = sensitivity. Spec = specificity. * Data recorded in percentage. ‡ Systematic review and meta-analysis. § Preschoolers. ¶ School-children. || Teenagers. |
||||||